(Q47206731)

11 January 2018

meta-analysis

0 references

title

Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery (English)

1 reference

11 January 2018

0 references

1 reference

venous thromboembolism

1 reference

Mismetti P

1

1 reference

11 January 2018

Laporte S

2

1 reference

11 January 2018

Darmon JY

3

1 reference

11 January 2018

Buchmüller A

4

1 reference

11 January 2018

Decousus H

5

1 reference

11 January 2018

language of work or name

English

0 references

publication date

1 July 2001

1 reference

11 January 2018

British Journal of Surgery

published in

1 reference

11 January 2018

volume

88

1 reference

11 January 2018

issue

7

1 reference

11 January 2018

page(s)

913-930

1 reference

11 January 2018

Low molecular weight heparin in prevention of perioperative thrombosis

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Prophylaxis of postoperative thromboembolism with low molecular weight heparins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Unexpectedly high rate of phlebographic deep venous thrombosis following elective general abdominal surgery among patients given prophylaxis with low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Low-molecular-weight heparins and Daflon for prevention of postoperative thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Incidence and prevention of deep venous thrombosis occurring late after general surgery: randomised controlled study of prolonged thromboprophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Controlled clinical study of the efficacy of a new low molecular weight heparin administered subcutaneously to prevent post-operative deep venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Randomized, controlled trial of low molecular weight heparin vs. no deep vein thrombosis prophylaxis for major colon and rectal surgery in Asian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Clinical efficacy of low molecular weight heparin in postoperative thrombosis prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: a co-operative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin) in the prophylaxis of thromboembolic complications of abdominal oncological surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Comparison of low molecular weight heparin vs. unfractionated heparin in gynecological surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Fluorescent Probes as Tools to Assess the Receptor for the Urokinase-Type Plasminogen Activator on Tumor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Prevention of thromboembolism in hysterectomies with low molecular weight heparin Fragmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Prophylaxis of thromboembolism in general surgery: comparison between standard heparin and Fragmin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Comparison of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin, with or without dihydroergotamine, in abdominal hysterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Comparison of low molecular weight heparin vs. unfractionated heparin in gynecological surgery. II: Reduced dose of low molecular weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Post-surgical deep vein thrombosis prevention: Evaluation of the risk/ benefit ratio of fractionated and unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Patients at risk of venous thromboembolism--clinical results with reviparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Prospective randomized clinical study in general surgery comparing a new low molecular weight heparin with unfractionated heparin in the prevention of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

[Efficacy and tolerance of Fraxiparine in the prevention of deep vein thrombosis in general surgery performed with medullar conduction anesthesia]

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

Antithrombotic therapy for venous thromboembolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01800.X

10.1046/J.0007-1323.2001.01800.X

21 January 2018

Identifiers

DOI

1 reference

11 January 2018

1 reference

11 January 2018